Dermatology Digital and Technology Solutions for the Treatment of Skin Conditions during the COVID-19 Pandemic

Have you created digital and technology solutions for the treatment of skin conditions during the COVID-19 Pandemic?

These awards recognise innovative, well-designed and credible healthcare digital and technology solutions for the treatment of skin conditions during the COVID-19 pandemic and delivered via ANY digital or technology channel or channels, online or offline.

Who can enter?

We welcome entries from healthcare professionals, in-house teams, agencies and consultancies. Digital and technology solutions entered should be UK or Ireland based even if they are used globally, and for work conducted from January 2020 – March 2021.

Where applicable you must state which digital provider you worked with on the assignment and what the budget was that was allocated to this work by band. Failure to specify a budget band may lead to disqualification of your entry by the judges. If you are unable to provide budget band information, please state the reason in your submission.

Band A below £10,000
Band B £10,001-£25,000
Band C £25,001-£50,000
Band D £50,001-£150,000
Band E over £150,000

Please ensure that any websites/digital media you refer to in your entry can be accessed by our panel of judges, therefore include any passwords or specific links when submitting your entry and keep links open until the end of thejudging day (Thursday 27 May).

Judging Criteria and points: The judges will be focusing on the following areas when scoring your entry. Write your entry accordingly

Summary: Provide background & brief overview of the initiative.


Innovation: Creativity or innovation in content, presentation/use of the medium and usability for service user, demonstrate evidence of how you adapted your care delivery with COVID -19.


Project planning: Describe the identified need for the initiative. Organisation, stakeholders, planned time frames and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?


Methods: Putting plans into action. What did you do? Describe how the initiative was implemented and outline the procedures and tools you used to measure outcomes.


Safety considerations: Risk assessment, clinical governance, ethics and any other safety considerations and how these were successfully addressed.


Effectiveness: Demonstrate project effectiveness to illustrate efficiency improvement(s), how the initiative brought about change to support improved outcomes and what was the impact for people with skin conditions.


User feedback: Evidence of support from a range of interested stakeholders, e.g. healthcare professionals and/or service users. Please include statements. Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.


Cost efficiency and economic viability: Evidence of, and maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget.


Sustainability and evidence for sharing practice and dissemination:

  1. Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders and funding sources
  2. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones
  3. For achieved spread of initiative to wider geographical areas or other healthcare setting include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken.


Remember:entries without results will not be judged

Quality In Care Dermatology

in association with

Quality In Care Dermatology

QiC Dermatology is partnered by:

Supported by:
  • 2021 KEY DATES
  • Open for entry: 16 November 2020
  • Extended Nomination Deadline: Monday 3 May 2021
  • Judging day: 27 May 2021
  • Awards ceremony: 09 September 2021